Bosh sahifa506197 • BOM
add
Bliss GVS Pharma Ltd
Yopilish kursi
159,20 ₹
Kunlik diapazon
158,10 ₹ - 164,50 ₹
Yillik diapazon
92,25 ₹ - 184,95 ₹
Bozor kapitalizatsiyasi
17,07 mlrd INR
Oʻrtacha hajm
100,88 ming
Narx/foyda
27,27
Dividend daromadliligi
0,31%
Asosiy maydon
NSE
Bozor yangiliklari
The Motley Fool
21 soat oldin
Why Realty Income Stock Significantly Underperformed the S&P 500 in 2024
0,038%
1,83%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,18 mlrd | 2,74% |
Joriy xarajat | 682,58 mln | 6,38% |
Sof foyda | 242,60 mln | -42,66% |
Sof foyda marjasi | 11,14 | -44,22% |
Har bir ulushga tushum | — | — |
EBITDA | 414,11 mln | -23,69% |
Amaldagi soliq stavkasi | 28,04% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,20 mlrd | 34,93% |
Jami aktivlari | 12,83 mlrd | 7,13% |
Jami passivlari | 2,34 mlrd | 0,06% |
Umumiy kapital | 10,48 mlrd | — |
Tarqatilgan aksiyalar | 105,02 mln | — |
Narxi/balansdagi bahosi | 1,66 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 7,68% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 242,60 mln | -42,66% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Tashkil etilgan
1984
Sayt
Xodimlar soni
831
